Novel 1'-methyl-5'-norcarbocyclic adenosine phosphonic acid analogues were synthesized using an acyclic stereoselective route from commercially available 3,3-diethoxy-propan-1-ol 4. The synthesized nucleoside phosphonate 19 and phosphonic acid 21 were subjected to antiviral screening against various viruses.
Introduction
Nucleosides play a major role in combating tumors and viruses, with modifications of natural nucleosides leading to novel antitumor and/or antiviral agents, including branched nucleosides such as DMDC, 1 CNDAC, 2 ECyd, 3 4'α-C-ethenylthymidine, 4 and 4'α-C-ethynylthymidine 5 as potent antiviral or antitumor agents.
The 1'-substituted nucleosides such as angustmycin 1 6 and hydantocidin 2 7 are herbicidal and affect plant growth ( Figure 1 ). However, only a few examples of 1'-substituted nucleosides of defined absolute stereochemistry are reported. 8 The scarcity of examples of 1'-substituted nucleosides may be due to the synthetic difficulties for elaborating a necessary tertiary carbon center. We therefore developed efficient methodology to synthesize furanosyl or cyclopentane rings containing stereochemically defined tertiary carbons.
5'-Nornucleoside phosphonic acid analogues such as d4AP 3 9 as potential anti-HIV agents have encouraged the search for novel nucleosides in this class of compounds. A nucleoside 5'-nornucleoside phosphonate analogue is essentially a nucleoside monophosphate analogue. 10 The phosphonate has certain advantages over its phosphate counterpart as it is metabolically stable because its phosphorus-carbon bond is not susceptible to hydrolytic cleavage. 11 Moreover, a phosphonate nucleoside can skip the requisite first phosphorylation, which is a crucial step for the activation of nucleosides. This is frequently a limiting event in the phosphorylation sequence, which ultimately leads to triphosphates.
Because 1'-branched nucleoside analogues and 5'-nornucleoside phosphate have excellent biological activities, we sought to synthesize and evaluate a novel class of nucleosides comprising 1'-methyl branched carbocyclic-5'-norcarbocyclic phosphonic acid.
Results and Discussion
The target compounds were prepared from commercially available starting material 4 as shown in Scheme 1. The alcohol functional group of 4 was protected with benzyl bromide to give the acetal derivative 5, which was subject to the acidic hydrolysis conditions using p-toluene sulfonic acid (PTSA) to give the aldehyde derivative 6. Aldehyde functional 6 was sub- Figure 2 . NOE difference between the hydrogens of 14a and 14b.
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Reagents: i) MeLi, diethylether; ii) Grubbs (II) catalyst, CH 2 Cl 2 ; iii) 6-chloropurine, DIAD, dioxane/DMF; iv) TBAF, THF. ject to carbonyl addition using vinylmagnesium bromide to provide the tertiary alcohol derivative 7 as a racemic mixture. The corresponding tertiary hydroxyl group of 7 was successfully silylated using t-butyldimethylsilyl trifluoromethanesulfonate (TBDMSOTf) with 2,6-lutidine 12 to give the fully protected compound 9. Removal of the benzyl protecting group of 8 under dissolving metal reduction furnished desired alcohol 9, which was oxidized to the aldehyde 10 using Swern oxidation conditions (DMSO, oxalyl chloride, TEA). The aldehyde 10 was again subjected to nucleophilic Grignard conditions with vinylmagnesium bromide to give divinyl 11, which was subjected to allylic oxidation conditions (MnO2, CCl4) to provide 12. Dienone 12 was subjected to addition by methyllithium in dry diethyl ether to give 13 as an inseparable isomer, which was subjected to ring-closing metathesis (RCM) conditions using 2nd generation Grubbs catalyst 13 to provide cyclopentenol 14a (41%) and 14b (40%), which were readily separated by silica gel column chromatography. The NOE experiments with cyclopentenols 14a and 14b confirmed these assignments. As expected, NOE enhancements were found between the cis-oriented hydrogens. Upon irradiation of C1-CH3, weak NOE patterns were observed at the proximal hydrogens of compound 14b
To synthesize the desired 5'-norcarbocyclic adenine nucleoside analogue, the protected cyclopentenol 14b was treated with 6-chloropurine in the presence of diisopropyl azodicarboxylate (DIAD) and PPh3 to give 15 with a correct configuration. The choice of solvent system, temperature, and procedure are critical in the selective nucleobase coupling using Mitsunobu conditions (Scheme 2). Slow addition of diisopropyl azodicarboxylate (DIAD) to a mixture of cyclopentenol 14b, triphenylphosphine, and the 6-chloropurine in anhydrous dioxane-DMF mixture solvent gave a yellow solution that was stirred for 2 h at -20 o C to give protected 6-chloropurine analogue 15. The silyl protection group was removed with tetrabutylammonium fluoride (TBAF) to give 16. Treatment of the nucleoside 16 with diethylphosphonomethyl triflate prepared from diethyl hydroxymethylphosphonate yielded the nucleoside phosphonate 17.
14 The chlorine group of 17 was then transformed to amine with methanolic ammonia at 70 o C to give a corresponding adenine phosphonate derivative 18. 15 The resultant nucleoside phosphonate mimics the overall shape and geometry of a nucleoside monophosphate. Bishydroxylation 16 of the double bond in 18 was accomplished with a catalytic amount of osmium tetraoxide (OsO4) and 4-methyl-morpholine N-oxide (NMO) as the oxidant to give the dihydroxylated isomer 19 (37%) as a major reaction product compared to minor isomer 20 (17%) (Scheme 3). Their stereochemistries were also readily determined by NOE. These stereochemical outcomes suggest that two bulky groups such as the diethyl phosphonate and purine nucleobase reinforce the steric hindrance of the β-faces. 17 Hydrolysis of 19 by treatment with bromotrimethylsilane in CH3CN in the presence of 2,6-lutidine gave an adenine phosphonic acid derivative 21.
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Conclusions
As shown in Table 1 , the synthesized nucleoside phosphonate 19 and phosphonic acid 21 were subjected to antiviral screening against herpes simplex virus, coxsakie B virus, poliovirus, and human immunodeficiency virus according to the assay procedure. 19 They only showed weak antiviral activity (19, EC50 = 62.7 µM) and (21, EC50 = 41.2 µM) against herpes simples virus type 1 without cytotoxicity. On the basis of potent antiviral and antitumor activity of 1'-branched nucleoside analogues, we have accomplished the stereoselective synthesis of its carbocyclic version starting from 3,3-diethoxy-propan-1-ol. The synthesis of other nucleoside analogues with different nucleobases (T, C, U), their SATEprodrugs and stability study will be reported elsewhere.
Experimental Section
Melting points were determined on a Mel-temp II laboratory device and are uncorrected. NMR spectra were recorded on a JEOL 300 Fourier transform spectrometer (JEOL, Tokyo, Japan); chemical shifts are reported in parts per million (δ) and signals are reported as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet) and dd (doublet of doublets). UV spectra were obtained on a Beckman DU-7 spectrophotometer (Beckman, South Pasadena, CA, USA). MS spectra were collected in electrospray ionization (ESI) mode. The elemental analyses were performed using a Perkin-Elmer 2400 analyzer (Perkin-Elmer, Norwalk, CT, USA). TLC was performed on Uniplates (silica gel) purchased from Analtech Co. (7558, Newark, DE, USA). All reactions were carried out under an atmosphere of nitrogen unless otherwise specified. Dry dichloromethane, benzene, and pyridine were obtained by distillation from CaH2. Dry THF was obtained by distillation from Na and benzophenone immediately prior to use.
(3,3-Diethoxy-propoxymethyl)-benzene (5). To a stirred suspension of NaH (0.7 g, 29.16 mmol) in THF (75 mL), a solution of 4 (3.13 g, 21.15 mmol) in dry THF (30 mL) was added slowly, and stirred for 1 h at rt. To this mixture, benzyl bromide (4.27 g, 25 mmol) was added, and stirred overnight at rt. The mixture was quenched using a saturated ammonium chloride solution (10 mL) and further diluted with water (100 mL). The mixture was extracted with EtOAc (100 mL) twice. The combined organic layer was washed with brine, dried over anhydrous MgSO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (EtOAc/hexane, 1:10) to give compound 4 (4.33g, 86%) as a colorless oil: (
±)-[1-(2-Benzyloxyethyl)-allyloxy]-t-butyldimethylsilane (8).
To a stirred solution of tertiary alcohol 7 (138.4 mg, 0.72 mmol) and 2,6-lutidine (0.6 mL, 6.14 mmol) in dry methylene chloride (10 mL) was added t-butyldimethylsilyltrifluoromethane sulfonate (TBDMSOTf, 0.9 mL, 3.07 mmol) at -10 o C. The reaction mixture was warmed to room temperature, and stirred for 3 h at the same temperature. The mixture was quenched by saturated sodium bicarbonate (5 mL) and water (60 mL) was added. The mixture was extracted with ethyl acetate (70 mL) twice. The combined organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to dryness. The residue was purified by silica gel column chromatography (EtOAc/hexane, 1:35) to give 8 (185 mg, 84%) as a colorless oil: (
±)-3-(t-Butyldimethylsilanyloxy)-pent-4-en-1-ol (9).
Ammonia (approximately 10 mL) was condensed into a flask containing a solution of benzyl ether 8 (167 mg, 0.546 mmol) in dry tetrahydrofuran (4 mL) at -78 o C. To this mixture was added a minimum amount of metallic lithium sufficient to maintain a blue color, and the resulting deep blue solution was stirred at -78 o C for 4 min. Methanol was added dropwise at the same temperature until the blue color disappeared. The colorless solution was stirred for 30 min at -78 o C, and then solid ammonium chloride (ca. 4.0 g) was added. After stirring for 1 h at -78 o C, ammonia was allowed to evaporate. Diethyl ether (40 mL) was added, and the mixture was dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography (EtOAc/hexane, 1:15) to give 9 (101 mg, 86%) as a colorless oil (
rel)-(3R and 3S,5S)-5-(t-Butyldimethylsilanyloxy)-hepta-1,6-dien-3-ol (11).
Divinyl derivative 11 was synthesized from aldehyde 10 using a similar procedure as described for 7 as a diastereomeric mixture: yield 81%; ( thyl-hepta-1,6-dien-3-ol (13) . To a solution of compound 12 (2.8 g, 11.66 mmol) in dry diethyl ether (60 mL), methyllithium (8.7 mL, 1.6 M solution in diethyl ether) was added slowly at -78 o C. After 1 h, a saturated NH4Cl solution (15 mL) was added, and the reaction mixture was warmed slowly to room temperature. The mixture was diluted with water (100 mL) and extracted with EtOAc (100 mL) twice. The combined organic layer was washed with water, dried over anhydrous MgSO4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (EtOAc/hexane, 1:15) to give 13 (2.1 g, 71%) as a diastereomeric mixture: ( pent-2-enol (14a) and (rel)-(1R,4S)-4-(t-butyldimethylsilanyloxy)-1-methyl-cyclopent-2-enol (14b) . To a solution of 13 (456 mg, 1.78 mmol) in dry methylene chloride (7 mL) was added 2nd generation Grubbs catalyst (36.0 mg 0.0424 mmol). The reaction mixture was refluxed overnight and cooled to room temperature. The mixture was concentrated in vacuo, and the residue was purified by silica gel column chromatography (EtOAc/hexane, 1:10) to give cyclopentenol 14a (166 mg, 41%) and 14b (162 mg, 40%). Data for 14a: 
rel)-(1R and 1S,4S)-4-(t-Butyldimethylsilanyloxy)-3-me-
rel)-(1S,4S)-4-(t-Butyldimethylsilanyloxy)-1-methyl-cyclo-
